Concepedia

Quantitative Drug-Susceptibility in Patients Treated for Multidrug-Resistant Tuberculosis in Bangladesh: Implications for Regimen Choice

Scott K. Heysell, Shahriar Ahmed, Sara Sabrina Ferdous, Md. Siddiqur Rahman Khan, S. M. Mazidur Rahman, Jean Gratz, Md. Toufiq Rahman, Asif Mahmud, Eric R. Houpt, Sayera Banu

PLoS ONE · 2015 · 24 citations · 30 references

DOIFull text

Open access

Abstract

Quantitative MIC testing could impact MDR-TB regimen choice in Bangladesh. Comparative trials of higher dose or later generation fluoroquinolone, within class change from kanamycin to amikacin, and inclusion of rifabutin appear warranted.

References

30

Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes

Gail L. Woods, Barbara A. Brown‐Elliott, Patricia S. Conville et al. · 2011 · 1.2K citations

, , +3

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

Neel R. Gandhi, Paul Nunn, Keertan Dheda et al. · The Lancet · 2010 · 1K citations

, , +12

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

Catharina Boehme, Mark P. Nicol, Pamela Nabeta et al. · The Lancet · 2011 · 1K citations · Full text

, , +13

Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes.

G Canetti, Wallace Fox, A G Khomenko et al. · PubMed · 1969 · 774 citations · Full text

, , +24

Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis

Armand Van Deun, Aung Kya Jai Maug, Md Abdul Hamid Salim et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 650 citations